Low levels of high density lipoprotein increase the severity of cerebral white matter changes: Implications for prevention and treatment of cerebrovascular diseases

Current Alzheimer Research

Volumn 7, Issue 6, 2010, Pages 534-539

  Crisby, M ^a   Bronge, L ^b   Wahlund, L O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apolipoprotein E; High Density Lipoprotein; Magnetic Resonance Imaging; White Matter Changes

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ALLELE; ARTICLE; BRAIN DAMAGE; BRAIN DISEASE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GENOTYPE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER; WHITE MATTER CHANGE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BRAIN; BRAIN MAPPING; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; LIPOPROTEINS, HDL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78549235412     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720510792231694     Document Type: Article

References (33)

1. Hachinski VC, Potter P, Mersky H. Leukoariosis. Arch Neurol 44: 21-23 (1987).
2. Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L. Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 21(10): 1419-23 (1990).
3. Inzitari D. Leukoaraiosis: an independent risk factor for stroke? Stroke 34(8): 2067-71 (2003).
4. Henon H, Vroylandt P, Durieu I, Pasquier F, Leys D. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 34(12): 2935-40 (2003).
5. Streifler JY, Eliasziw M, Benavente OR, Alamowitch S, Fox AJ, Hachinski VC, Barnett HJM for the North American Symtomatic Carotid Endarterectomy Trial group. Stroke 33:1651-5 (2002).
6. Streifler JY, Eliasziw M, Benavente OR, Alamowitch S, Fox AJ, Hachinski V, et al. North American Symptomatic Carotid Endarterectomy Trial Group. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 34(8):1913-6 (2003).
7. Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 57(7):1216-22 (2001).
8. van der Flier MW, van Straaten ECW, Barkhof F, Ferro JM, Pantoni L, Basile AM, et al. on behalf of the LADIS study group. Small vessel disease and mild cognitive deficits in non-disabled elderly: the LADIS study. Stroke 36(10): 2116-20 (2005).
9. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, et al. Vascular risk factors and leuko-araiosis. Arch Neurol 44(1): 42-7 (1987).
10. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 13 (suppl 2): 7-10 (2002).
11. Brown WR, Moody DM, Thore CR, Challa VR. Apoptosis and Leukoariosis. Am J Neuroradiol 21: 79-82 (2000).
12. Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 15(10): 1858-60 (2001).
13. Lee S-H, Bae H-J, Yoom B-W, Kim H, Kim D-E, Roh J-K. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on griadient-echo magnetic resonance imaging. Analysis of risk factors for multifocal signal loss lesions. Stroke 33: 2845-9 (2002).
14. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 149(2): 351-6 (1987).
15. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31(3): 545-8 (1990).
16. Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59(2): 193-7 (2002).
17. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8(6): 737-41 (1988)
18. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 17(1): 107-13 (1997).
19. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256(20): 2835-8 (1986).
20. Tanne D, Yaari S, Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke 28(1): 83-7 (1997).
21. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 2: 707-717 (1977).
22. Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation 100(6): 594-8 (1999).
23. Cockerill GW, Huehns TY, Weerasinghe A, et al. Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1-Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation. Circulation 103(1): 108-12 (2001).
24. Dimayuga P, Zhu J, Oguchi S, Chyu KY, Xu XO, Yano J, et al. Reconstituted HDL containing human apolipoprotein A-I reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apo E null mice. Biochem Biophys Res Commun 264: 465-468 (1999).
25. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, et al. CNS synaptogenesis promoted by by glia-derived cholesterol. Science 294: 1354-57 (2001).
26. Michikawa M, Fan QW, Isobe I, Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 74(3): 1008-16 (2000).
27. Robins SJ. Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density lipoprotein Intervention Trial. Am J Cardiol 88: 19N-23N (2001).
28. Paterno R, Ruocco A, Postiglione A, Hubsch A, Andresen I, Lang MG. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 17(2-3): 204-11 (2004).
29. Nofer JRB, Levkau I, Wolinska R, Junker M, Fobker A, van Eckardstein U, et al. Assmann. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276, 34480-34485 (2001).
30. DeKroon R, Robinette JB, Hjelmeland AB, Wiggins E, Blackwell M, Mihovilovic M, et al. APOE4-VLDL Inhibits the HDL-Activated Phosphatidylinositol 3-Kinase/Akt Pathway via the Phosphoinositol Phosphatase SHIP2. Circul Res 99(8): 829-836 (2006).
31. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63(10):1868-75 (2004).
32. Wolf H. Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol 56: 745-748 (2004).
33. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 28(8): 1556-62 (2008).